4th Quarter - Report

MCDERMOTT+ LLC for LYMPHEDEMA ADVOCACY GROUP

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act

LobbyistCovered position, as disclosed
KATIE WALDO —
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood
EMMA ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 518 (116th), H.R. 3 (116th), H.R. 1948 (116th), H.R. 1865 (116th)

Medicare/Medicaid MMM

Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). H.R. 1865 - Further Consolidated Appropriations Act, 2020 H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act

LobbyistCovered position, as disclosed
KATIE WALDO —
RODNEY WHITLOCK 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood
EMMA ZIMMERMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (116th), S. 518 (116th), H.R. 1865 (116th), H.R. 1948 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.